The 2021 NIH Progenitor Cell Translation Consortium (PCTC) Annual Conference, hosted by the UAB Department of Biomedical Engineering, will be held virtually this year on Wednesday, September 29 and Thursday, September 30.
The national meeting will feature keynote speakers Eric Olson, Ph.D., Scientific Advisory Board Chairman of Cardurion and the founding chair of the Department of Molecular Biology at UT Southwestern Medical Center, as he speaks on “Gene Therapy for Muscular Dystrophy Syndromes,” and Robert Langer, Sc.D., professor in the MIT Department of Biological Engineering.
The goal of the PCTC, a consortium of the National Heart, Lung and Blood Institute (NHLBI), is to translate advances in progenitor cell biology toward application to heart, lung, and blood diseases.
This collaborative conference, focusing on gene and cell therapy topics, is hosted and organized by Jay Zhang, M.D., Ph.D., chair, UAB Department of Biomedical Engineering; Timothy Kamp, M.D., Ph.D., professor, Cardiovascular Medicine, University of Wisconsin; and Nenad Bursac, Ph.D., professor of Biomedical Engineering, Duke University.
The symposium provides a forum for trainees and junior investigators to present their work in the areas of gene editing, induced pluripotent stem cells, and therapeutics in the organ systems of heart, blood, and lungs. Additional topics will include vascular tissue engineering, cardiac development, exosomes, microRNAs, and mitochondria.
Videos from the 2019 symposium presentations may be viewed on YouTube here. Some presentations are excluded at the presenters’ request.